A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

<div>Mean intraocular pressure (IOP) at each visit in the modified intent-to-treat population. Data are presented as mean + standard deviation (SD) for TFC and mean − SD for DFC. Statistical significance was determined using the 2-sample <i>t</i>-test. DFC: dual fixed-combination; TFC: triple fixed-combination.</div>

Journal of Ophthalmology

fig1

Figure 1

Figure 1: A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure 

Figure 1 | A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure 